| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $894K | — |
| R&D Expense | $72.0M | +137.8% |
| SG&A Expense | $27.5M | +0.7% |
| Operating Income | -$105.5M | -74.1% |
| Net Income | -$78.0M | +83.7% |
| EPS (Basic) | -$0.51 | +91.1% |
| EPS (Diluted) | -$0.51 | +91.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.8M | -85.4% |
| Accounts Receivable | $5.0M | +857.8% |
| Current Assets | $151.6M | -38.2% |
| Total Assets | $173.6M | -30.6% |
| Current Liabilities | $28.0M | +105.5% |
| Long-term Debt | $1.9M | -49.2% |
| Total Liabilities | $36.6M | -18.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$81.6M | -57.4% |
| Capital Expenditures | $14.2M | +412.5% |
| Investing Cash Flow | -$117.9M | -4160.4% |
| Financing Cash Flow | -$4.1M | -101.4% |
| Free Cash Flow | -$95.8M | -75.4% |
| Stockholders' Equity |
| $137.0M |
| -33.2% |